AstraZeneca launches LabTalk
AstraZeneca launched a new science blog, LabTalk, providing an online forum where scientists can discuss cutting-edge science and innovation.
LabTalk offers a platform for scientists to share innovative ideas and approaches. From discovery in the lab, to making a meaningful difference in the lives of patients, LabTalk seeks to foster the creativity and innovation shared amongst scientists in an easy-to-use, online forum.
“The value of ‘LabTalk’ is not only to raise the profile of innovative science, but it also gives AstraZeneca the opportunity to hear from our peers,” said Oliver Stohlmann, vice president of R&D Communications. “Over time we hope to build up a rich library of content that will help tell the R&D story, both from AstraZeneca’s and others’ perspectives. This is something we’ve started with the recent ‘Letters from the Lab’ features, but with LabTalk we have the functionality to also engage with readers. What’s more, it will create a platform to showcase the great work of our scientists, making our work more transparent to potential collaborators.”
Head over to www.labtalk.astrazeneca.com and let us know what you think.